NCT02277522 · Interventional trial
CD19 Redirected Autologous T Cells for Hodgkin Lymphoma
Overall registry status Terminated
Early Phase 1
Conditions Hodgkin Lymphoma With no Available Curative Treatment Options Who Have a Limited Prognosis
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory